Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis.
Saved in:
| Title: | Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. |
|---|---|
| Authors: | Rubio‐Rivas, Manuel1 (AUTHOR) mrubio@bellvitgehospital.cat, Forero, Carlos G.2 (AUTHOR), Mora‐Luján, José María1 (AUTHOR), Montero, Abelardo1 (AUTHOR), Formiga, Francesc1 (AUTHOR), Homs, Narcís A.1 (AUTHOR), Albà‐Albalate, Joan1 (AUTHOR), Sánchez, Laura1 (AUTHOR), Rello, Jordi2,3,4 (AUTHOR), Corbella, Xavier1,2 (AUTHOR) |
| Source: | Pharmacotherapy. Nov2021, Vol. 41 Issue 11, p884-906. 23p. |
| Database: | Academic Search Ultimate |
| ISSN: | 02770008 |
|---|---|
| DOI: | 10.1002/phar.2627 |
